InDevR Inc., a provider of analytical technologies for vaccines and biotherapeutics, has raised $9m in Series B financing.
ADVERTISEMENT
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
InDevR Inc., a provider of analytical technologies for vaccines and biotherapeutics, has raised $9m in Series B financing.

